Genetic Testing for Lynch Syndrome
Customize your policy alerts
Sign up for Presbyterian Health Plan Policy 7.5 alerts
Get alerted when Policy 7.5 changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage and prior authorization for genetic and molecular testing used to evaluate Lynch syndrome for Presbyterian Health Plan commercial, Medicaid managed, and Medicare Advantage members. Coverage follows the most recent NCCN guideline and remains subject to the member’s specific benefit plan and Schedule of Benefits.
Code 0130U was added to the policy and is listed among the codes requiring prior authorization.
Code 81436 was removed because it was deleted effective 01/01/2025.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.